Globus Medical stock in focus Globus Medical (GMED) is back on investor radars after recent trading left the shares with a mixed return profile, including a small gain over the past 3 months but a ...

Wondering whether Dutch Bros at US$50.35 is priced for more growth or already running ahead of itself? This breakdown will help you assess what you are really paying for. The stock has been volatile, ...

Samsung Electronics anticipates Q1 operating profit of 40.5 trillion won ($26.9B), driven by booming AI memory chip demand ...

We see an expectations investing opportunity if the company achieves anything close to its historical growth rates.

Barclays shares have slumped recently, but a big gap between price and fair value has opened, offering nimble long-term investors an opportunity to consider. The post Down 19%! Here’s why Barclays ...

Relative to its peer companies, Merck KGaA has a compelling valuation from which to realize its upside potential through its ...

By Benedict ASHIEDU In a recent transaction involving a West African fintech company, the initial valuation using standard EV ...

Lockheed Martin is positioned for ~35% upside, with a DCF-derived target price of $843.21. Click here to find out why LMT ...

Wondering if Semtech at US$72.16 is offering value or asking too much? This article walks through what the current price could mean for you as an investor. The stock has pulled back with a 5.7% ...

The case examined whether share premium could be taxed without proof of unaccounted funds. The Tribunal held that Section 56(2)(viib) cannot be invoked without establishing such inflow, leading to ...